Erythema Nodosum Overview
Definition:
• EN is an inflammatory condition characterized by tender, red nodules, typically located on the shins.
Nature:
• It is a form of panniculitis, involving inflammation of the subcutaneous fat.
Significance:
• EN often serves as a marker for underlying systemic diseases.
Common Causes of EN:
• Infectious Agents:
- Streptococcal infections (most common)
- Mycobacterium tuberculosis
- Histoplasma capsulatum
- Yersinia enterocolitica
- Chlamydia trachomatis
- Mycoplasma pneumoniae
- Coccidioides immitis
- Epstein-Barr virus
• Systemic Diseases:
- Sarcoidosis
- Inflammatory bowel disease (Crohn’s disease, ulcerative colitis)
- Behçet's disease
• Medications:
- Sulfonamides
- Oral contraceptives
- Penicillins
- Omeprazole
- Hepatitis B vaccine
• Other Factors:
- Pregnancy
- Malignancies (e.g., non-Hodgkin lymphoma, pancreatic cancer)
- Idiopathic (no identifiable cause in 30–50% of cases)
Clinical Presentation of Erythema Nodosum (EN):
• EN typically presents as the sudden onset of painful, erythematous, warm nodules or plaques, most commonly located on the anterior aspects of the lower legs (shins).
• The lesions are usually bilateral but may be asymmetric, and they range in size from 1 to 5 cm. Patients may also report systemic symptoms such as fever, malaise, arthralgia (especially in the ankles and knees), and fatigue.
• The nodules evolve over several days, starting as bright red and becoming violaceous, then fading to a bruise-like appearance before resolving spontaneously over 2 to 8 weeks without ulceration or scarring.
Diagnostic Approach:
Clinical Evaluation:
• Detailed patient history and physical examination.
Laboratory Tests:
• Complete blood count (CBC)
• Erythrocyte sedimentation rate (ESR)
• C-reactive protein (CRP)
• Antistreptolysin O (ASO) titer
• Throat culture
• Tuberculin skin test
• Chest radiograph (especially to assess for sarcoidosis)
Histopathology:
• Skin biopsy may reveal septal panniculitis without vasculitis
Management Strategies:
Address Underlying Cause:
• Treat infections, manage systemic diseases, discontinue offending drugs.
Symptomatic Treatment:
• Nonsteroidal anti-inflammatory drugs (NSAIDs) for pain and inflammation.
• Bed rest and leg elevation.
• Compression therapy.
• Potassium iodide for persistent cases.
• Corticosteroids or colchicine in refractory cases.
Prognosis:
• EN is generally self-limiting, resolving within 3–6 weeks.
• Recurrence is possible, especially if the underlying cause persists.
#Erythema #Nodosum #Diagnosis #Management